Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Charles C. Roberts being referenced
Safety of Infliximab Treatment in Pediatric Patients with Inflammatory Bowel Disease
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Charles C. Roberts | 436 | 272 | 160 | 41 | 800 | |
| Concetta Sferlazzas | 241 | 178 | 322 | 36 | 769 | |
| G. Lock | 429 | 135 | 169 | 48 | 891 | |
| Anna Bossi | 151 | 83 | 168 | 45 | 819 | |
| Ayhan Gazi Kalaycı | 267 | 227 | 113 | 63 | 801 | |
| Sebuh Kuruğoğlu | 326 | 41 | 238 | 65 | 754 | |
| Donald J. Scholten | 403 | 62 | 164 | 46 | 928 | |
| P Mogle | 399 | 55 | 370 | 49 | 802 | |
| L. E. Swischuk | 467 | 52 | 217 | 41 | 721 | |
| WH McAlister | 326 | 36 | 179 | 47 | 651 | |
| Charles H. Brown | 605 | 67 | 96 | 42 | 910 |
All Works
Loading papers...